Renal replacement therapy: How can we contain the costs?

The Lancet

Volumn 383, Issue 9931, 2014, Pages 1783-1785

  Vanholder, Raymond ^a   Van Biesen, Wim ^a   Lameire, Norbert ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL KIDNEY; CHRONIC KIDNEY DISEASE; COMORBIDITY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; GLOMERULUS FILTRATION RATE; HEALTH CARE COST; HEMODIALYSIS; HOSPITAL ADMISSION; HUMAN; INFORMED CONSENT; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LIVING DONOR; NOTE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; QUALITY OF LIFE; REIMBURSEMENT; RENAL REPLACEMENT THERAPY; REVERSE OSMOSIS; SCORING SYSTEM; DRUG COST; END STAGE RENAL DISEASE; RISK FACTOR;

COST CONTROL; HEALTH CARE COSTS; HUMANS; KIDNEY FAILURE, CHRONIC; RENAL REPLACEMENT THERAPY;

IMMUNOSUPPRESSIVE AGENT;

EID: 84901218183     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(14)60721-2     Document Type: Note

References (13)

1. Swanepoel CR, Wearne N, Okpechi IG. Nephrology in Africa-not yet uhuru. Nat Rev Nephrol 2013; 9: 610-22.
2. Lameire N, Van Biesen W. The initiation of renal-replacement therapy-just-in-time delivery. N Engl J Med 2010; 363: 678-80.
3. Icks A, Haastert B, Gandjour A, et al. Costs of dialysis - a regional population-based analysis. Nephrol Dial Transplant 2010; 25: 1647-52.
4. Vanholder R, Davenport A, Hannedouche T, et al. Reimbursement of dialysis: a comparison of seven countries. J Am Soc Nephrol 2012; 23: 1291-98.
5. Laupacis A, Keown P, Pus N, et al. A study of the quality of life and cost-utility of renal transplantation. Kidney Int 1996; 50: 235-42.
6. Rubin HR, Fink NE, Plantinga LC, Sadler JH, Kliger AS, Powe NR. Patient ratings of dialysis care with peritoneal dialysis vs hemodialysis. JAMA 2004; 291: 697-703.
7. Jassal SV, Krishna G, Mallick NP, Mendelssohn DC. Attitudes of British Isles nephrologists towards dialysis modality selection: a questionnaire study. Nephrol Dial Transplant 2002; 17: 474-77.
8. Kleophas W, Reichel H. International study of health care organization and financing: development of renal replacement therapy in Germany. Int J Health Care Finance Econ 2007; 7: 185-200.
9. Murtagh FE, Marsh JE, Donohoe P, Ekbal NJ, Sheerin NS, Harris FE. Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5. Nephrol Dial Transplant 2007; 22: 1955-62.
10. Robinson BM, Zhang J, Morgenstern H, et al. Worldwide, mortality risk is high soon after initiation of hemodialysis. Kidney Int 2014; 85: 158-65.
11. Couchoud C, Labeeuw M, Moranne O, et al. A clinical score to predict 6-month prognosis in elderly patients starting dialysis for end-stage renal disease. Nephrol Dial Transplant 2009; 24: 1553-61.
12. Ponce P, Marcelli D, Guerreiro A, et al. Converting to a capitation system for dialysis payment-the Portuguese experience. Blood Purif 2012; 34: 313-24.
13. Desai AA, Bolus R, Nissenson A, et al. Is there "cherry picking" in the ESRD Program? Perceptions from a dialysis provider survey. Clin J Am Soc Nephrol 2009; 4: 772-77.